Fund Holdings — GILEAD SCIENCES, INC.

Total Portfolio Value:
$1.94B
Total Bought:
$0
Total Sold:
$85.80M
Net Transaction:
-$85.80M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Arcus Biosciences, Inc.(RCUS)31,424,76031,424,7600$427.38M$748.85M38.69%+$321.48M
Lakefront Biotherapeutics NVADR(LKFT)16,707,47716,707,4770$578.75M$550.62M28.45%-$28.13M
Arcellx Inc
COMMON STOCK
6,720,8036,720,8030$551.78M$438.20M22.64%-$113.58M
Assembly Biosciences Inc4,505,3914,505,3910$115.34M$153.23M7.92%+$37.89M
Kyverna Therapeutics, Inc.(KYTX)4,126,1194,126,1190$24.76M$38.79M2.00%+$14.03M
Xilio Therapeutics, Inc.(XLO)9,105,4519,105,4510$7.67M$5.83M0.30%-$1.84M
Tango Therapeutics, Inc.(TNGX)4,854,4430-4,854,443$40.78M$0—-$40.78M
Cypherpunk Technologies Inc.(CYPH)5,319,1480-5,319,148$2.41M$0—-$2.41M
Merus N V452,5270-452,527$42.61M$0—-$42.61M
Page 1 of 1
GILEAD SCIENCES, INC. — 13F Holdings — Q4 2025 | TickerTrail